PMID: 11912378Mar 26, 2002Paper

Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression

The Journal of Urology
Sten Holmang, Sonny L Johansson

Abstract

We studied the relationship of first cystoscopy findings with recurrence and progression rates in a large, population based series of patients with bladder cancer. All 463 patients with an initial diagnosis of stage Ta-T1 bladder cancer in western Sweden in 1987 to 1988 were followed at least 5 years. The 355 patients who were treated with transurethral resection only until repeat cystoscopy or longer were selected for this report. Negative first cystoscopy findings were associated with significantly decreased recurrence and progression rates for all grades, and for stage Ta and T1 tumors. However, some patients with initial high grade carcinoma (WHO 2 to 3) had stage progression despite negative first cystoscopy. On multivariate analyses first cystoscopy findings and papillary urothelial neoplasm of low malignant potential versus grades 1 to 3 but not stage and the number of tumors had prognostic significance for time to recurrence. Only first cystoscopy findings and grade had prognostic significance for time to stage progression. Our data support other groups who recommend a less intense cystoscopy followup schedule in patients with negative cystoscopy findings 3 months after initial transurethral bladder resection. We recomm...Continue Reading

Citations

Sep 1, 2005·Der Urologe. Ausg. A·M SeitzC Stief
Nov 12, 2005·Virchows Archiv : an International Journal of Pathology·Eva CompératAnnick Vieillefond
Apr 17, 2003·Journal of the National Cancer Institute·Deborah SchragColin B Begg
Apr 9, 2009·Journal of the National Cancer Institute·Gary H LymanStephen J Freedland
Dec 11, 2008·Cancer Treatment Reviews·Annemiek M E WalenkampDirk T Sleijfer
May 3, 2005·The Urologic Clinics of North America·Harry W Herr
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dipen J ParekhGuido Dalbagni
Apr 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ju-Seog LeeIn-Sun Chu
Dec 19, 2003·The Urologic Clinics of North America·S Machele Donat
Jan 10, 2006·Urology·Richard J SylvesterKarl Heinz Kurth
Jun 3, 2014·Current Opinion in Urology·Matthew Mossanen, John L Gore
May 3, 2005·International Journal of Surgical Pathology·Rodolfo Montironi, Antonio Lopez-Beltran
Jan 14, 2011·Nature Reviews. Urology·Johannes Falke, J Alfred Witjes
Sep 22, 2018·Current Opinion in Urology·Iris S G BrummelhuisEdward M Messing
May 16, 2006·The Journal of Urology·Timothy D Jones, Liang Cheng
Mar 30, 2010·BJU International·Paolo PuppoUNKNOWN AURO.it guideline committee
Dec 5, 2008·Scandinavian Journal of Urology and Nephrology. Supplementum·Antonio Lopez-Beltran
Jun 9, 2019·Der Urologe. Ausg. A·G B SchulzC G Stief

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.